Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More
Xconomy
DECEMBER 14, 2018
The patent holder, the University of Toronto, gave companies the right to manufacture insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version. In the nearly 100 years since insulin’s discovery, no generic version has become available in the U.S.
Let's personalize your content